Spironolactone Dosing Guidelines

Indication-Specific Dosing

• The American Heart Association recommends an initial dose of 12.5-25 mg daily for heart failure patients, with a target maintenance dose of 25-50 mg daily 2, 3, 4, 5
• For liver cirrhosis with ascites, the maximum dose is 400 mg daily, often requiring combination with loop diuretics for optimal effect 1, 7

Dosing Considerations

• The American College of Cardiology recommends careful monitoring of potassium and renal function in patients with eGFR 30-49 mL/min/1.73m², with consideration of reduced dosing (12.5-25 mg daily or every other day) 2, 3, 6
• Spironolactone is contraindicated in patients with eGFR <30 mL/min/1.73m² due to risk of hyperkalemia 2, 6

Monitoring Requirements

• The European Society of Cardiology recommends checking potassium and renal function before initiation, 1 and 4 weeks after starting treatment, and 1 and 4 weeks after dose increases 4, 5
• Monthly monitoring is recommended for the first 3 months, then every 3-6 months 3, 6

Risk Factors for Hyperkalemia

• The Journal of the American College of Cardiology identifies serum creatinine >1.6 mg/dL, baseline potassium >5.0 mEq/L, and concomitant use of ACE inhibitors or ARBs as risk factors for hyperkalemia 8, 6

Common Side Effects

• Hyperkalemia is a dose-dependent side effect, more common at higher doses 4
• Gynecomastia or breast pain occurs in approximately 10% of men 4
• Anti-androgenic effects, such as hyposexuality and erectile dysfunction, can occur 1, 7

Clinical Pearls

• For liver cirrhosis, higher doses of spironolactone may be needed due to secondary hyperaldosteronism 1, 7
• When hyperkalemia occurs (K+ >5.5 mmol/L), consider reducing the dose by half; if K+ >6.0 mmol/L, discontinue immediately 4, 5
• Eplerenone may be substituted for spironolactone in men experiencing gynecomastia 4, 5